Kalle Mattila
kalmat@utu.fi |
2 of 4
- Observational study on the evolution of systemic treatments for advanced renal cell carcinoma in Southwest Finland between 2010 and 2021 (2023)
- Therapeutic Advances in Urology
- Paikallisesti edenneen ihomelanooman hoito ja ihomelanooman esiliitännäishoito (2023)
- Duodecim
- Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland: A real-world evidence multicenter study (2023)
- Cancer Medicine
- Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma (2023)
- Acta Dermato-Venereologica
- Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor (2022)
- Acta Oncologica
- Edenneen munuaissyövän hoito (2022)
- Duodecim
- Immuuniaktivaation vapauttajien, kaksoisspesifisten vasta-aineiden ja CAR-T-soluhoitojen sydänhaitat (2022)
- Duodecim
- Novel prognostic factors for advanced melanoma and localized renal cell carcinoma (2022) Mattila Kalle E.
- Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy (2022)
- Cancers
- Retrospective, Registry-based, Cohort Investigation of Clinical Outcomes in Patients with Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma in Finland (2022)
- Acta Dermato-Venereologica
UTU Research Portal